Voice outcome measures after flexible endoscopic injection laryngoplasty

Objective To report voice outcome measures after injection laryngoplasty using the transnasal or transoral flexible endoscopic technique. Methods A retrospective review of all patients who underwent flexible endoscopic injection laryngoplasty between June 2010 and August 2016 was carried out. Only t...

Full description

Saved in:
Bibliographic Details
Published in:World journal of otorhinolaryngology - head and neck surgery 2018-06, Vol.4 (2), p.130-134
Main Authors: Hamdan, Abdul‐Latif, Rizk, Marwan, Khalifee, Elie, Ziade, Georges, Kasti, Maher
Format: Article
Language:English
Subjects:
Flexible endoscopic
Injection
Laryngoplasty
Review and Research Paper
Transnasal
Transoral
Vocal fold paralysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To report voice outcome measures after injection laryngoplasty using the transnasal or transoral flexible endoscopic technique. Methods A retrospective review of all patients who underwent flexible endoscopic injection laryngoplasty between June 2010 and August 2016 was carried out. Only those patients who had pre‐ and post‐injection voice outcome measures recorded were included. Voice outcome measures recorded included perceptual voice evaluation using GRBAS, Voice Handicap Index‐10 (VHI‐10), maximum phonation time (MPT) and closed quotient (CQ) before and after treatment. Results Forty‐six patients were identified, of which 32 had pre‐ and post‐injection voice outcome measures recorded. There were 19 males and 13 females. The mean age was 56.97 years (range 20–86 years) and the most common indication was unilateral vocal fold paralysis. Thirteen patients had a transnasal flexible endoscopic injection), while 19 patients were injected transorally. Following injection laryngoplasty, there was significant improvement in the mean grade of dysphonia (2.81 vs. 1.22, P 
ISSN:2095-8811
2589-1081
DOI:10.1016/j.wjorl.2018.04.005